Literature DB >> 28978471

Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent.

Diogo Gomes-Silva1, Malini Mukherjee2, Madhuwanti Srinivasan3, Giedre Krenciute4, Olga Dakhova3, Yueting Zheng3, Joaquim M S Cabral5, Cliona M Rooney6, Jordan S Orange7, Malcolm K Brenner3, Maksim Mamonkin8.   

Abstract

Antigen-independent tonic signaling by chimeric antigen receptors (CARs) can increase differentiation and exhaustion of T cells, limiting their potency. Incorporating 4-1BB costimulation in CARs may enable T cells to resist this functional exhaustion; however, the potential ramifications of tonic 4-1BB signaling in CAR T cells remain unclear. Here, we found that tonic CAR-derived 4-1BB signaling can produce toxicity in T cells via continuous TRAF2-dependent activation of the nuclear factor κB (NF-κB) pathway and augmented FAS-dependent cell death. This mechanism was amplified in a non-self-inactivating gammaretroviral vector through positive feedback on the long terminal repeat (LTR) promoter, further enhancing CAR expression and tonic signaling. Attenuating CAR expression by substitution with a self-inactivating lentiviral vector minimized tonic signaling and improved T cell expansion and anti-tumor function. These studies illuminate the interaction between tonic CAR signaling and the chosen expression platform and identify inhibitory properties of the 4-1BB costimulatory domain that have direct implications for rational CAR design.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  4-1BB; T cells; adoptive T cell therapy; chimeric antigen receptor; costimulation

Mesh:

Substances:

Year:  2017        PMID: 28978471      PMCID: PMC5645034          DOI: 10.1016/j.celrep.2017.09.015

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  34 in total

Review 1.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  ICAM-1-dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation.

Authors:  Nicholas A Zumwalde; Eisuke Domae; Matthew F Mescher; Yoji Shimizu
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

3.  Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B.

Authors:  I K Jang; Z H Lee; Y J Kim; S H Kim; B S Kwon
Journal:  Biochem Biophys Res Commun       Date:  1998-01-26       Impact factor: 3.575

4.  T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.

Authors:  Daniel W Lee; James N Kochenderfer; Maryalice Stetler-Stevenson; Yongzhi K Cui; Cindy Delbrook; Steven A Feldman; Terry J Fry; Rimas Orentas; Marianna Sabatino; Nirali N Shah; Seth M Steinberg; Dave Stroncek; Nick Tschernia; Constance Yuan; Hua Zhang; Ling Zhang; Steven A Rosenberg; Alan S Wayne; Crystal L Mackall
Journal:  Lancet       Date:  2014-10-13       Impact factor: 79.321

5.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

Review 6.  Regulation of intercellular adhesion molecule-1 (CD54) gene expression.

Authors:  K A Roebuck; A Finnegan
Journal:  J Leukoc Biol       Date:  1999-12       Impact factor: 4.962

7.  CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.

Authors:  Diogo Gomes-Silva; Madhuwanti Srinivasan; Sandhya Sharma; Ciaran M Lee; Dimitrios L Wagner; Timothy H Davis; Rayne H Rouce; Gang Bao; Malcolm K Brenner; Maksim Mamonkin
Journal:  Blood       Date:  2017-05-24       Impact factor: 22.113

Review 8.  Activation-induced cell death in T cells.

Authors:  Douglas R Green; Nathalie Droin; Michael Pinkoski
Journal:  Immunol Rev       Date:  2003-06       Impact factor: 12.988

Review 9.  Is HIV infection a TNF receptor signalling-driven disease?

Authors:  Georges Herbein; Kashif Aziz Khan
Journal:  Trends Immunol       Date:  2008-02       Impact factor: 16.687

10.  4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Authors:  Adrienne H Long; Waleed M Haso; Jack F Shern; Kelsey M Wanhainen; Meera Murgai; Maria Ingaramo; Jillian P Smith; Alec J Walker; M Eric Kohler; Vikas R Venkateshwara; Rosandra N Kaplan; George H Patterson; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

View more
  85 in total

1.  Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery.

Authors:  Cesar Sommer; Hsin-Yuan Cheng; Duy Nguyen; Danielle Dettling; Yik Andy Yeung; Janette Sutton; Moustafa Hamze; Julien Valton; Julianne Smith; Ivana Djuretic; Javier Chaparro-Riggers; Barbra J Sasu
Journal:  Mol Ther       Date:  2020-06-19       Impact factor: 11.454

2.  Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy.

Authors:  Clara H Karches; Mohamed-Reda Benmebarek; Moritz L Schmidbauer; Mathias Kurzay; Richard Klaus; Martina Geiger; Felicitas Rataj; Bruno L Cadilha; Stefanie Lesch; Constanze Heise; Ramona Murr; Johannes Vom Berg; Martin Jastroch; Daniel Lamp; Jian Ding; Peter Duewell; Gerhard Niederfellner; Claudio Sustmann; Stefan Endres; Christian Klein; Sebastian Kobold
Journal:  Clin Cancer Res       Date:  2019-07-08       Impact factor: 12.531

3.  Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform.

Authors:  Julian Rydzek; Thomas Nerreter; Haiyong Peng; Sabrina Jutz; Judith Leitner; Peter Steinberger; Hermann Einsele; Christoph Rader; Michael Hudecek
Journal:  Mol Ther       Date:  2018-11-20       Impact factor: 11.454

4.  4-1BB enhancement of CAR T function requires NF-κB and TRAFs.

Authors:  Gongbo Li; Justin C Boucher; Hiroshi Kotani; Kyungho Park; Yongliang Zhang; Bishwas Shrestha; Xuefeng Wang; Lawrence Guan; Nolan Beatty; Daniel Abate-Daga; Marco L Davila
Journal:  JCI Insight       Date:  2018-09-20

5.  Towards antigen-specific Tregs for type 1 diabetes: Construction and functional assessment of pancreatic endocrine marker, HPi2-based chimeric antigen receptor.

Authors:  Ilian A Radichev; Jeongheon Yoon; David W Scott; Kurt Griffin; Alexei Y Savinov
Journal:  Cell Immunol       Date:  2020-09-30       Impact factor: 4.868

6.  NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma.

Authors:  Xin Xu; Wei Huang; Andras Heczey; Daofeng Liu; Linjie Guo; Michael Wood; Jingling Jin; Amy N Courtney; Bin Liu; Erica J Di Pierro; John Hicks; Gabriel A Barragan; Ho Ngai; Yuhui Chen; Barbara Savoldo; Gianpietro Dotti; Leonid S Metelitsa
Journal:  Clin Cancer Res       Date:  2019-09-04       Impact factor: 12.531

Review 7.  CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?

Authors:  Brooke L Prinzing; Stephen M Gottschalk; Giedre Krenciute
Journal:  Expert Rev Anticancer Ther       Date:  2018-03-16       Impact factor: 4.512

8.  Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation.

Authors:  Sonia Guedan; Avery D Posey; Carolyn Shaw; Anna Wing; Tong Da; Prachi R Patel; Shannon E McGettigan; Victoria Casado-Medrano; Omkar U Kawalekar; Mireia Uribe-Herranz; Decheng Song; J Joseph Melenhorst; Simon F Lacey; John Scholler; Brian Keith; Regina M Young; Carl H June
Journal:  JCI Insight       Date:  2018-01-11

9.  Chimeric antigen receptor-induced BCL11B suppression propagates NK-like cell development.

Authors:  Marcel Maluski; Arnab Ghosh; Jessica Herbst; Vanessa Scholl; Rolf Baumann; Jochen Huehn; Robert Geffers; Johann Meyer; Holger Maul; Britta Eiz-Vesper; Andreas Krueger; Axel Schambach; Marcel Rm van den Brink; Martin G Sauer
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

10.  CD19 CAR T Cells for the Treatment of Pediatric Pre-B Cell Acute Lymphoblastic Leukemia.

Authors:  Holly L Pacenta; Theodore W Laetsch; Samuel John
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.